SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-23-000052
Filing Date
2023-09-18
Accepted
2023-09-18 16:18:10
Documents
13
Period of Report
2023-09-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K anab-20230914.htm   iXBRL 8-K 27510
  Complete submission text file 0001370053-23-000052.txt   196950

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20230914.xsd EX-101.SCH 2177
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20230914_def.xml EX-101.DEF 8934
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20230914_lab.xml EX-101.LAB 33136
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20230914_pre.xml EX-101.PRE 20656
7 EXTRACTED XBRL INSTANCE DOCUMENT anab-20230914_htm.xml XML 2817
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 231261403
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences